Schernthaner G - Search Results

1

The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics.

Kazda C, Gallwitz B, Simó R, Guzmán JR, Kraus P, Nicolay C, Rose L, Schernthaner G. Kazda C, et al. Among authors: schernthaner g. Diabetes Obes Metab. 2009 Dec;11(12):1131-7. doi: 10.1111/j.1463-1326.2009.01091.x. Epub 2009 Sep 16. Diabetes Obes Metab. 2009. PMID: 19758357

2

Impact of postprandial and fasting glucose concentrations on HbA1c in patients with type 2 diabetes.

Schernthaner G, Guerci B, Gallwitz B, Rose L, Nicolay C, Kraus P, Kazda C. Schernthaner G, et al. Diabetes Metab. 2010 Nov;36(5):389-94. doi: 10.1016/j.diabet.2010.04.004. Epub 2010 Jul 2. Diabetes Metab. 2010. PMID: 20598608 Clinical Trial.

3

Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) study.

Schernthaner G, Rosas-Guzmán J, Dotta F, Guerci B, Simó R, Festa A, Kiljański J, Zhou M, Gallwitz B. Schernthaner G, et al. Diabetes Obes Metab. 2015 Jul;17(7):689-98. doi: 10.1111/dom.12471. Epub 2015 May 8. Diabetes Obes Metab. 2015. PMID: 25846577 Clinical Trial.

4

Changes in body composition after 9 months of treatment with exenatide twice daily versus glimepiride: comment letter on Jendle et al.

Gallwitz B, Haupt A, Kraus P, Peters N, Petto H, Dotta F, Petto H, Poll L, Rose L, Schernthaner G. Gallwitz B, et al. Among authors: schernthaner g. Diabetes Obes Metab. 2010 Dec;12(12):1127-8. doi: 10.1111/j.1463-1326.2010.01309.x. Diabetes Obes Metab. 2010. PMID: 20977586 No abstract available.

5

Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years.

Wilding JP, Woo V, Rohwedder K, Sugg J, Parikh S; Dapagliflozin 006 Study Group. Wilding JP, et al. Diabetes Obes Metab. 2014 Feb;16(2):124-36. doi: 10.1111/dom.12187. Epub 2013 Aug 29. Diabetes Obes Metab. 2014. PMID: 23911013 Clinical Trial.

6

Efficacy and tolerability of saxagliptin compared with glimepiride in elderly patients with type 2 diabetes: a randomized, controlled study (GENERATION).

Schernthaner G, Durán-Garcia S, Hanefeld M, Langslet G, Niskanen L, Östgren CJ, Malvolti E, Hardy E. Schernthaner G, et al. Diabetes Obes Metab. 2015 Jul;17(7):630-8. doi: 10.1111/dom.12461. Epub 2015 Apr 7. Diabetes Obes Metab. 2015. PMID: 25761977 Clinical Trial.

7

Medical antihyperglycaemic treatment of type 2 diabetes mellitus: update of the evidence-based guideline of the German Diabetes Association.

German Diabetes Association; Matthaei S, Bierwirth R, Fritsche A, Gallwitz B, Häring HU, Joost HG, Kellerer M, Kloos Ch, Kunt T, Nauck M, Schernthaner G, Siegel E, Thienel F. German Diabetes Association, et al. Among authors: schernthaner g. Exp Clin Endocrinol Diabetes. 2009 Oct;117(9):522-57. doi: 10.1055/s-0029-1239559. Epub 2009 Oct 29. Exp Clin Endocrinol Diabetes. 2009. PMID: 19876795 No abstract available.

8

Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial.

Wilding JP, Woo V, Soler NG, Pahor A, Sugg J, Rohwedder K, Parikh S; Dapagliflozin 006 Study Group. Wilding JP, et al. Ann Intern Med. 2012 Mar 20;156(6):405-15. doi: 10.7326/0003-4819-156-6-201203200-00003. Ann Intern Med. 2012. PMID: 22431673 Free article. Clinical Trial.

9

Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls.

Bannister CA, Holden SE, Jenkins-Jones S, Morgan CL, Halcox JP, Schernthaner G, Mukherjee J, Currie CJ. Bannister CA, et al. Among authors: schernthaner g. Diabetes Obes Metab. 2014 Nov;16(11):1165-73. doi: 10.1111/dom.12354. Epub 2014 Jul 31. Diabetes Obes Metab. 2014. PMID: 25041462

10

Safety and efficacy of the dipeptidyl peptidase-4 inhibitor linagliptin in elderly patients with type 2 diabetes: a comprehensive analysis of data from 1331 individuals aged ≥ 65 years.

Schernthaner G, Barnett AH, Patel S, Hehnke U, von Eynatten M, Woerle HJ. Schernthaner G, et al. Diabetes Obes Metab. 2014 Nov;16(11):1078-86. doi: 10.1111/dom.12321. Epub 2014 Jul 3. Diabetes Obes Metab. 2014. PMID: 24865132 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

598 results

Search Page

Filters